Holen Sie sich die Stockscreener-App
39.36
1.52%
0.59
Handel nachbörslich:
39.78
0.42
+1.07%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HROW?
Forum
Prognose
Aktiensplit
Harrow Inc Aktie (HROW) Neueste Nachrichten
What does recent volatility data suggest for Harrow Inc.Weekly Earnings Recap & Daily Risk Controlled Trade Plans - newser.com
Harrow, Inc. (NASDAQ:HROW) On The Verge Of Breaking Even - 富途牛牛
Will Harrow Inc. stock pay special dividendsOil Prices & Community Supported Trade Ideas - newser.com
How hedge fund analytics apply to Harrow Inc. stock2025 Trade Ideas & Fast Gain Swing Alerts - newser.com
What insider trading reveals about Harrow Inc. stockTrade Exit Summary & Low Risk Profit Maximizing Plans - newser.com
Harrow, Inc. Hits Day Low of $41.03 Amid Price Pressure - Markets Mojo
Advocate Group LLC Buys New Stake in Harrow, Inc. $HROW - MarketBeat
Is it too late to sell Harrow Inc.Earnings Growth Report & Real-Time Chart Breakout Alerts - newser.com
What data driven models say about Harrow Inc.’s futurePortfolio Risk Report & Weekly High Conviction Trade Ideas - newser.com
What institutional flow reveals about Harrow Inc.Dollar Strength & Entry and Exit Point Strategies - newser.com
Using data tools to time your Harrow Inc. exitJuly 2025 Movers & Weekly Chart Analysis and Guides - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Harrow (NASDAQ:HROW) - MarketBeat
Harrow, Inc. (HROW): A Bull Case Theory - Insider Monkey
Will Harrow's (HROW) Affordability Push and New Leadership Shift its Long-Term Growth Trajectory? - simplywall.st
Could Harrow’s (HROW) New Pricing Program Redefine Its Patient Access Advantage? - Yahoo Finance
Harrow, Inc. (HROW) Stock Analysis: Exploring The 61.71% Upside Potential - DirectorsTalk Interviews
ImprimisRx Announces Leadership Changes - GlobeNewswire
Is Harrow Inc. stock dividend yield sustainableWeekly Profit Analysis & Daily Chart Pattern Signal Reports - newser.com
Harrow names Frank Mullery as CEO of ImprimisRx subsidiary - Investing.com
Harrow Health (HROW) Appoints New Leadership at ImprimisRx - GuruFocus
Harrow Health Announces New Leadership at ImprimisRx - TipRanks
Harrow names Frank Mullery as CEO of ImprimisRx subsidiary By Investing.com - Investing.com Canada
ImprimisRx announces leadership changes - MarketScreener
Leadership Appointments at ImprimisRx: Frank Mullery Named CEO and Bridseida Cruz as Head of Quality - Quiver Quantitative
Frank Mullery named CEO; Bridseida Cruz named Head of Quality at ImprimisRx, Harrow subsidiary - Stock Titan
Intraday pattern recognizer results for Harrow Inc.Bull Run & Technical Pattern Recognition Alerts - newser.com
How to escape a deep drawdown in Harrow Inc.July 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
Assessing Harrow’s Value After a 22.8% Surge and Recent Earnings Release - simplywall.st
How to track smart money flows in Harrow Inc.Market Volume Report & Smart Money Movement Alerts - newser.com
Harrow (NASDAQ:HROW) Trading Down 4.9%Should You Sell? - MarketBeat
A Fresh Look at Harrow (HROW) Valuation Following Recent Share Price Momentum - simplywall.st
Harrow, Inc. (NASDAQ:HROW) Looks Just Right With A 27% Price Jump - simplywall.st
Research Analysts Issue Forecasts for Harrow Q3 Earnings - MarketBeat
How to use Fibonacci retracement on Harrow Inc.2025 Top Gainers & High Yield Stock Recommendations - newser.com
B. Riley Comments on Harrow's Q4 Earnings (NASDAQ:HROW) - MarketBeat
Harrow announces leadership changes, Andrew Boll to serve as President and CFO - MSN
B. Riley Securities Reiterates Harrow (HROW) Buy Recommendation - Nasdaq
HROW: B. Riley Securities Increases Price Target to $74, Reitera - GuruFocus
Harrow to purchase Melt Pharmaceuticals - Eyes On Eyecare
0.90%
2.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):